Sign in

Judy 🫘

@jbvienna.bsky.social
530 followers 63 following 18 posts

🫘 Nephrology resident in Austria Interested in palliative care Hobbies: 🇯🇵🎻🎤📚

PostsRepliesMedia
Reposted by Judy 🫘
Joshua J. Friedman @joshuajfriedman.com · 02/06/2025
Some interesting insights here, including that people are much more influenced by *people they follow* switching platforms than by their own *followers* switching platforms. Preprint: "Why Academics are Leaving Twitter for Bluesky" arxiv.org/abs/2505.24801
Why Academics Are Leaving Twitter for Bluesky
By Dorian Quelle, Frederic Denker, Prashant Garg, and Alexandre Bovet (bios omitted from alt text)
June 2, 2025
Abstract
We analyse the migration of 300,000 academic users from Twitter /X to Bluesky between 2023 and early 2025, combining rich bibliometric data, longitudinal social-media activity, and a novel cross-platform identity-matching pipeline. We show that 18% of scholars in our sample transitioned, with transition rates varying sharply by discipline, political expression, and Twitter engagement but not by traditional academic metrics. Using time-varying Cox models and a matched-pairs design, we isolate genuine peer influence from homophily.
We uncover a striking asymmetry whereby information sources drive migration far more powerfully than audience, with this influence decaying exponentially within a week. We further develop an ego-level contagion classifier, revealing that simple contagion drives two-thirds of all exits, shock-driven bursts account for 16%, and complex contagion plays a marginal role. Finally, we show that scholars who rebuild a higher fraction of their former Twitter networks on Bluesky remain significantly more active and engaged. Our findings provide new insights onto theories of network externalities, directional influence, and platform migration, highlighting information sources' central role in overcoming switching costs.
211051250
Reposted by Judy 🫘
American Journal of Kidney Diseases @ajkd.bsky.social · 18/08/2025
Delivery of Palliative Care in the Last Year of Life to Individuals Receiving Maintenance Dialysis: A Population-Level Cross-Sectional Study bit.ly/Bonares25OI #OpenAccess #CKD
011
Reposted by Judy 🫘
@IM_Crit_ @imcrit.bsky.social · 16/08/2025
(Basic) ICU Hemodynamic “Secrets” - Part1: I know you know them, but let’s remind ourselves of some basic hemodynamic "secrets":
11611
Reposted by Judy 🫘
American Journal of Kidney Diseases @ajkd.bsky.social · 14/08/2025
New Commentary by Madhumitha Rajagopal on the #AJKDBlog: Unseen, Unheard: The Silent Strain on Dialysis Caregivers bit.ly/RajagopalBlog (FREE) Article by Driehuis et al: bit.ly/Driehuis25OI
043
Reposted by Judy 🫘
josh farkas 💊 @pulmcrit.bsky.social · 14/08/2025
P-values are fraught with hazard, but SO IS BAYESIAN STATISTICS the Achilles heel of Bayesian stats is that someone determines a pre-test probability distribution (usually arbitrarily) The pre-test probability is often too high This inflates the final posterior probability 🧵 #1/4 #EMIMCC
4137
Reposted by Judy 🫘
American Journal of Kidney Diseases @ajkd.bsky.social · 11/08/2025
Health Outcome Preferences and Trade-Offs Among Older Adults With Advanced CKD: A Discrete Choice Experiment bit.ly/Schoot25OI #OpenAccess #CKD
001
Judy 🫘 @jbvienna.bsky.social · 08/08/2025
journals.lww.com/cjasn/abstra...
010
Reposted by Judy 🫘
American Journal of Kidney Diseases @ajkd.bsky.social · 23/07/2025
Editorial by Marie Evans, Jenny Lindberg, and Johan Sundelöf: Finding Barriers for the Implementation of Advanced Care Planning in Patients Receiving Dialysis bit.ly/AJKD25EvansED (FREE)
101
Reposted by Judy 🫘
American Journal of Kidney Diseases @ajkd.bsky.social · 19/07/2025
NEW on the #AJKDBlog: @maximalchange.bsky.social interviews the authors of a recent review of ADPKD, Sara S. Jdiaa and Reem A. Mustafa, and discusses prognosis, goals, and monitoring. bit.ly/Jdiaa25 (FREE)
043
Reposted by Judy 🫘
Eric Goffin @er-goffin.bsky.social · 18/07/2025
‘ Strawberry milkshake ´ dialysate in a Peritoneal Dialysis patient at PD onset ? What is your diagnosis ? ➡️ authors.elsevier.com/a/1lSI0_1y3u... @inesdufour.bsky.social @clemencebechade.bsky.social @lobbedezt.bsky.social @hswapnil.medsky.social @kidneyint.bsky.social
1128
Reposted by Judy 🫘
Nature Reviews Nephrology @natrevneph.nature.com · 18/07/2025
nature.com
Pregnancy-associated acute kidney injury — consensus report of the 32nd Acute Disease Quality Initiative workgroup
Nature Reviews Nephrology, Published online: 18 July 2025; doi:10.1038/s41581-025-00979-6Pregnancy-associated acute kidney injury is a risk factor for maternal and fetal morbidity and mortality and a driver of health inequity worldwide. This Consensus Statement from the Acute Disease Quality Initiative provides recommendations on the causes, diagnosis, management and follow-up of pregnancy-associated acute kidney injury.
096
Reposted by Judy 🫘
kireports.bsky.social @kireports.bsky.social · 14/07/2025
Long-term Outcome of #Adult Patients With #Membranous Nephropathy Treated With #Rituximab #VisualAbstract by @priti899.bsky.social www.kireports.org/ar...
073
Reposted by Judy 🫘
American Journal of Kidney Diseases @ajkd.bsky.social · 11/07/2025
Review by Anjana Gopal, Janine Farragher, Sarbjit V. Jassal, and Istvan Mucsi: Sleep Disorders in CKD bit.ly/GopalREV25 (FREE)
001
Judy 🫘 @jbvienna.bsky.social · 09/07/2025
doi.org/10.1093/ckj/...
010
Reposted by Judy 🫘
Nephrology Journal Club @nephjc.bsky.social · 07/07/2025
🎨Check out the beautiful #visualabstract by #NephJC intern @shelliefravel.bsky.social ⏰Chat happening on July 8, 9 pm EST www.nephjc.com/news/2025/7/...
nephjc.com
CONFIDENCE Visual Abstract — NephJC
Check out the beautiful visual abstract made by NephJC intern Michelle Fravel .
11714
Reposted by Judy 🫘
gearoidmm @gearoidmm.bsky.social · 06/07/2025
The trend in the US was to start at higher GFRs throughout the 2000s and this peaked in 2010 and since then there has been a small decline in mean GFR at initiation but imo it is still too high.
GFR at RRT initiation trend from 2002 to 2022. GFR and peaked in 2010
122
Reposted by Judy 🫘
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 06/07/2025
Interesting data from Alberta www.kidney-international.org/article/S008... in @kidneyint.bsky.social GFR < 15 is classified as ‘kidney failure’ in most studies - but about a third of them die before starting RRT. Is that glass half full or half empty? 🥃 #NephSky
Visual abstract - still needs work since KI doesn’t get professionals to do it! 🤷🏽‍♂️
4157
Reposted by Judy 🫘
ISNkidneycare @theisn.org · 04/07/2025
➡️ Cognitive impairment and physical dysfunction associated with unplanned dialysis initiation www.kireports.org/ar...
111
Reposted by Judy 🫘
NEJM.org @nejm.org · 01/07/2025
In the latest video in our partnership with @glaucomflecken.bsky.social, the REGENCY trial investigating the efficacy and safety of obinutuzumab when added to standard therapy in patients with active proliferative lupus nephritis is explained. Access the article for free: nej.md/DrG20
23911
Reposted by Judy 🫘
Joel Topf @kidneyboy.bsky.social · 05/05/2023
Summary: urinary anion gap is not a good measure of urine ammonium and should be abandoned. If you need to know the urinary ammonium, measure the urinary ammonium. 15/15
001
Reposted by Judy 🫘
American Journal of Kidney Diseases @ajkd.bsky.social · 21/06/2025
Determinants of Caregiver Burden Among Spouses of Patients With Kidney Failure: A Qualitative Study bit.ly/42kNvWq #OpenAccess #VisualAbstract
021
Reposted by Judy 🫘
markusathome @markusathome.bsky.social · 19/06/2025
GLP-1 Receptor Agonist Outcomes, Safety, and BMI Change in a National Cohort of Dialysis Patients by Drs. Orandi, McAdams-DeMarco et al. journals.lww.com/cjasn/abstra... GLP-1 RA use in DM 2 patients on HD was associated with weight loss, reduced mortality, higher chance of waitlisting.
022
Reposted by Judy 🫘
NephroPOCUS @nephropocus.bsky.social · 13/06/2025
#POCUS in #Nephrology: Enthusiasm Alone Won't Suffice; Training Is Key". @ajkd.bsky.social The final typeset version is out. Here is the open access link 🔗 authors.elsevier.com/a/1lFg5_6ClS... #Nephpearls #FOAMed
022
Reposted by Judy 🫘
ASN Publications @asnpublications.bsky.social · 12/06/2025
The rate of procedures for maintaining hemodialysis vascular access in new patients is 0.71 per year, with higher risks in adults with a primary central venous catheter. kidney.pub/KID0841 #ASNKidney360
131
Reposted by Judy 🫘
NEJM.org @nejm.org · 05/06/2025
In the CONFIDENCE trial in persons with chronic kidney disease and type 2 diabetes, combination therapy with finerenone and empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either drug alone. Full trial results: nej.md/4jEVbbk #ERA25 #MedSky #Nephrology
A graph of the least-squares mean ratio of the change from baseline in the urinary albumin-to-creatinine ratio in the full analysis population.
12916
Reposted by Judy 🫘
Hugo Diniz, MD 🇵🇹🇪🇺 @hugodiniz.medsky.social · 06/06/2025
ACHIEVE trial - Spironolactone in Hemodialysis stopped early... due to futility 😢 I had some hopes for this one. #ERA25
22211
Reposted by Judy 🫘
Kidney International @kidneyint.bsky.social · 02/06/2025
The Standardized Outcomes in Nephrology (SONG) initiative: a decade of harmonizing patient voices and research in #kidneydisease doi.org/10.1016/j.kint.2025.02.016 #NephSky #MedSky #chronickidneydisease #CKD
022
Reposted by Judy 🫘
Joel Topf @kidneyboy.bsky.social · 02/06/2025
This was a fun article to work on. Hope you enjoy it. Things We Do for No Reason™: Avoiding IV iodinated contrast material in patients with acute kidney injury or chronic kidney disease Journal of Hospital Medicine shmpublications.onlinelibrary.wiley.com/doi/10.1002/...
shmpublications.onlinelibrary.wiley.com
Things We Do for No Reason™: Avoiding intravenous iodinated contrast material in patients with acute kidney injury or chronic kidney disease
Click on the article title to read more.
78330
Reposted by Judy 🫘
American Journal of Kidney Diseases @ajkd.bsky.social · 16/05/2025
A Core Outcome Set for Trials in CKD: Report of the Standardized Outcomes in Nephrology–Chronic Kidney Disease (SONG-CKD) Stakeholder Workshops bit.ly/4gmbwzX
032
Reposted by Judy 🫘
Lucy Selman @lucyselman.bsky.social · 13/05/2025
📣 New paper now online @ckj-era.bsky.social: How do patient information documents present dialysis and conservative kidney management? A document analysis. academic.oup.com/ckj/advance-... @flissmurtagh.bsky.social @peolcsw.bsky.social @wolfsonpallcare.bsky.social @danafarber.bsky.social
Paper infographic about how patient information documents frame dialysis and conservative kidney management in inaccurate ways.
156
Reposted by Judy 🫘
ASN Publications @asnpublications.bsky.social · 14/03/2025
Could "Obi" replace "BeLi"? Authors in this article explore the efficacy and safety of obinutuzumab for managing active lupus nephritis. bit.ly/KN1703-06 @kdjhaveri.bsky.social #ASNKidneyNews
073
Reposted by Judy 🫘
American Journal of Kidney Diseases @ajkd.bsky.social · 14/02/2025
Association of Coprescribing of Gabapentinoid and Other Psychoactive Medications With Altered Mental Status and Falls in Adults Receiving Dialysis bit.ly/4jE4Wb3 #OpenAccess #VisualAbstract
001
Reposted by Judy 🫘
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 08/02/2025
Compared to biopsy for cause - protocol biopsy reveals upto 60% (!) still have active histologies features in #lupus nephritis despite complete or partial remission clinically Nor can immunological data #ISNWCN #NephSky
Protocol biopsy features in peeps on remission in lupusImmunology does not perfectly correlate with histology
162
Reposted by Judy 🫘
David Warner (he/him) @davidwarner2.bsky.social · 07/02/2025
Continuing our discussion on oncological emergencies from last week, let's tackle malignant hypercalcemia, which occurs in 20-30% of malignancies with a grim prognosis. A must-know🧵 for medicine trainees! #PhysiologyFriday #MedSky #NephSky #OncSky #Onconeph #MedStudentSky
101
Reposted by Judy 🫘
American Journal of Kidney Diseases @ajkd.bsky.social · 05/02/2025
A Core Outcome Set for Trials in CKD: Report of the Standardized Outcomes in Nephrology–Chronic Kidney Disease (SONG-CKD) Stakeholder Workshops bit.ly/4gmbwzX
011
Reposted by Judy 🫘
Paul A. Welling, MD @pawellingmd.bsky.social · 31/12/2024
The Aldosterone Paradox: A Skeetutorial:
media.tenor.com
a man stands in front of a blackboard with the words it 's paradoxical and yet it works
ALT: a man stands in front of a blackboard with the words it 's paradoxical and yet it works
15019
Reposted by Judy 🫘
Nathan Gray, MD, FACP @nathanagray.bsky.social · 04/02/2025
When discussing serious health issues with patients, it’s crucial to ask permission each time a new sensitive topic is broached… people may have specific needs, timing, or preferences they’d like to voice before you “go there.”
22511
Reposted by Judy 🫘
American Journal of Kidney Diseases @ajkd.bsky.social · 03/02/2025
Core Curriculum by Charmaine E. Lok, Theodore You, and Timmy Lee: Hemodialysis Vascular Access: Core Curriculum 2025 bit.ly/4ir8vAF (FREE)
142
Reposted by Judy 🫘
David Warner (he/him) @davidwarner2.bsky.social · 31/01/2025
As I gear up for residency, I've been reviewing some key medicine topics. I'm currently reviewing oncologic emergencies, starting with Tumor Lysis Syndrome. This is high yield content on the wards and the boards, so let's dive in! A 🧵 #PhysiologyFriday #MedSky #NephSky #MedStudentSky #Skytorial
144
Reposted by Judy 🫘
National Kidney Foundation @kidney.org · 28/01/2025
BREAKING NEWS: The FDA has approved Ozempic for patients with chronic kidney disease. This means the popular injection can be used to reduce the risk of kidney disease worsening, kidney failure and death from cardiovascular disease in patients with chronic kidney disease and diabetes.
cnbc.com
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves a gradual loss of kidney function.
12216
Reposted by Judy 🫘
Canada Healthwatch 🍁 @canadahealthwatch.ca · 25/01/2025
Sick of the stomach bug? Moderna is making a norovirus vaccine globalnews.ca/news/1097631... Get weekly updates: CanadaHealthwatch.ca/newsletter 🍁
close up shot of gloved hands holding a needled syringe with a "Norovirus" label on it
511019
Reposted by Judy 🫘
markusathome @markusathome.bsky.social · 24/01/2025
Join our new webinar NOW on YouTube! Nephroprotection 2025: "4 Pillars" & EASi-KIDNEY with our guests Dr. Doreen Zhu & Dr. Parminder Judge youtu.be/cpAel7yCW6I?... Moderators: Prof. Dr. Johannes Mann, @gunnarheine.bsky.social @marcussaemann.bsky.social
youtu.be
Nephroprotection 2025: "4 Pillars" & EASi-KIDNEY - Dr. Doreen Zhu & Dr. Parminder Judge (Oxford, UK)
YouTube video by MARKUS at HOMe
154
Reposted by Judy 🫘
Juan Carlos Q Vélez, MD @juancarlosqvelez.bsky.social · 19/01/2025
18/n so maybe the drug crystals cause injury as they travel down the nephron but they don’t end up absorbed into the renal parenchyma. As an example, atazanavir crystals do (PMID 32647771) @vipvargh.bsky.social @kireports.bsky.social
174
Reposted by Judy 🫘
Katie Wiskar @katiewiskar.bsky.social · 24/01/2025
Confession: I LOVE hyponatremia 🤓 (I know, I know. What can I say, I'm a true internist!) HypoNa is often feared, maligned, and misunderstood - but I promise it doesn't have to be scary! Here are my top 10 hyponatremia tips and tricks - a 🧵 #emimcc
1315848
Reposted by Judy 🫘
Jonathan Zuckerman MD PhD @jzrenalpath.bsky.social · 24/01/2025
Example of necrotizing lupus vasculopathy. Hilar arterioles with luminal immune complex deposit and mural necrosis. Ig deposition in lumen of vessel and fibrinogen staining by IF. #renalpath #pathsky #nephsky
0137
Reposted by Judy 🫘
Kidney International @kidneyint.bsky.social · 23/01/2025
Amoxicillin crystalluria during endocarditis treatment doi.org/10.1016/j.kint.2024.07.029 #KINephrologyImage #MedSky #NephSky #nephrotoxicity
1105
Reposted by Judy 🫘
Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 22/01/2025
Can the BP med cilnidipine cause gingival hyperplasia? Sure, it can. Here is one of my pts. #nephsky
141
Reposted by Judy 🫘
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 21/01/2025
#NephJC tonight Check out the beautiful visual abstract from @nephroseeker.medsky.social!
Visual abstract
075